The United States is set to phase out its HIV/AIDS funding support to South Africa through the President’s Emergency Plan for AIDS Relief (PEPFAR), a move that could significantly impact healthcare services for millions of people living with HIV in the country.
The funding, estimated at approximately $400 million annually, has been a critical pillar in South Africa’s fight against HIV/AIDS, helping to finance treatment programmes, prevention campaigns, and healthcare infrastructure. South Africa carries one of the world’s largest HIV burdens, with more than eight million people currently living with the virus.
Washington reportedly linked the decision to broader policy disagreements with Pretoria, highlighting growing diplomatic tensions between the two nations. The withdrawal marks the latest development in the increasingly strained relationship between the administration of US President Donald Trump and the South African government.
Health experts and advocacy groups have expressed concern that the reduction in funding could disrupt access to life-saving antiretroviral treatment, particularly for vulnerable communities that rely heavily on donor-supported programmes. They warn that any interruption in care could undermine years of progress made in reducing HIV-related deaths and new infections.
South African authorities have yet to outline how they intend to bridge the expected funding gap, but analysts say the government may face mounting pressure to increase domestic healthcare spending or seek alternative international partners.
The development underscores the broader geopolitical and policy challenges shaping relations between the United States and South Africa, with the consequences likely to be felt far beyond diplomatic circles.
